Get smart on an unfamiliar disease market
A fresh, primary research-grounded commercial assessment — without the time or cost of a full consulting engagement.
The usual options force a compromise
Internal research takes time, syndicated reports may be unavailable or outdated, and full consulting can require more than the decision warrants.
One framework. Four levels of depth.
Start with the decision you need to make – we'll scope the research to match. Each level builds on the one before it and includes structured secondary research, fresh KOL input, and senior interpretation.
Market Primer |
Commercial Assessment |
TPP Assessment |
Payer Insights |
|
|---|---|---|---|---|
| Level 1 | Level 2 | Level 3 | Level 4 | |
| Deliverable | Concise two-slide brief | Comprehensive commercial assessment | Commercial assessment plus TPP evaluation | Full assessment plus payer insights |
| Analyses Included | ||||
| Disease overview | ✓ | ✓ | ✓ | ✓ |
| Epidemiology | ✓ | ✓ | ✓ | ✓ |
| Diagnosis and current treatment | ✓ | ✓ | ✓ | ✓ |
| Unmet need | ✓ | ✓ | ✓ | ✓ |
| Pipeline | ✓ | ✓ | ✓ | ✓ |
| Pricing and reimbursement | – | ✓ | ✓ | ✓ |
| TPP testing and peak-sales forecast | – | – | ✓ | ✓ |
| Clinical development feasibility | – | – | ✓ | ✓ |
| Research Approach | ||||
| Secondary research and literature review | ✓ | ✓ | ✓ | ✓ |
| KOL interviews | 2 | 5 | 7 | 7 |
| HCP survey respondents | – | – | 25 | 25 |
| Payer interviews | – | – | – | 3 |
| Real-world claims analysis | Optional add-on, any level | |||
Geography: Available for either the U.S. or EU5: France, Germany, Italy, Spain, and the United Kingdom
See the full comparison of all four MarketVue® tiers — deliverables, analyses, and research approach side by side.
View All Levels →From market evidence to commercial direction
MarketVue® connects market evidence and stakeholder perspectives to clarify the opportunity and inform commercial direction.
Market Evidence
An integrated view of the disease, treatment, competitive, and access landscape.
Stakeholder Perspectives
Physician insights—and payer perspectives when included—interpreted in market context.
Unmet Need & Opportunity
Remaining needs, affected populations, and the size of the potential opportunity.
Differentiation Pathways
Where a new product could stand apart and create meaningful value.
Forward Market Outlook
How the standard of care, competition, and access are likely to evolve.
Why teams choose MarketVue®
"I need something beyond what I can do for myself with Google and without paying an extraordinary amount of money… REACH operates with the best aspects of primary research but then benefits like speed of syndicated reports."
"MarketVue® is very valuable to get fast reports and at the right level of detail. We were originally supposed to develop disease strategies but then we had a reorganization and resources were constrained. REACH is a great help to us."
"With MarketVue® reports, you can get 80–90% of output for 10% of the cost of custom consulting — this is great, especially for small clients like us whose budgets are tight, and we don't have a ton of FTEs."
Ready to get smart on your next disease market?
Tell us the disease, geography, and decision you're facing. We'll recommend the right scope.